ArticleVirulence
Risk based HIV retesting: back to the same old challenges.
Article in Virulence. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Patient acceptance of universal screening for hepatitis C virus infection.BMC infectious diseases · 2011Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An estimated 230,000 Americans are unaware that they have HIV infection. As a result, these individuals have not benefited from treatment for HIV infection and they may continue to spread the disease. In 2006, the Centers for Disease Control and Prevention (CDC) reported that 40% of adults aged 18-64 had been tested for HIV but only 10% had been tested within the last 12 months. A national survey conducted by the CDC in 2000 found that only about one-quarter of primary care providers and emergency physicians reported routinely testing their patients for HIV. To improve the performance of HIV testing, in 2006 the CDC issued recommendations that patients in all health care settings be offered universal, opt-out HIV testing. Since that time, several studies have demonstrated the feasibility of opt-out testing but barriers to implementation persist. Many states still require signed consent and counseling and other logistical challenges include: insufficient time, competing priorities, and inadequate reimbursement. Therefore, universal HIV testing remains an unrealized goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.